XPER compared with MNKD: revenue, margins and what each company keeps, and the suppliers and customers both name

XPERXperi Inc.

Mkt capRevenueRevenue

MNKDMannkind Corp

Mkt capRevenueRevenue

Compare

XPERXperi Inc.

MNKDMannkind Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

XPERXperi Inc.

5.43· pre 5.39· delayed

Mkt cap$261.0MRevenue$114MQ2 FY26Revenue$448MFY25

MNKDMannkind Corp

3.73· pre 3.80· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.2BRevenue$109MQ2 FY26Revenue$349MFY25

Compare

Pre-marketNov 4 '26delayed

XPERXperi Inc.

MNKDMannkind Corp

5.43pre 5.39delayed

Price

3.73pre 3.80delayed

$261.0M

Mkt cap

$1.2B

Q2 FY26$114M

Revenue

$109MQ2 FY26

FY25$448M

Revenue

$349MFY25

XPER5.43vsMNKD3.73Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

XPER: latest quarter is a loss; flow not drawable. MNKD: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only XPER 1

PNCPNC Bank, National Associationsupplier

Shared 0

No shared counterparties.

Only MNKD 4

UTHRUnited Therapeuticssupplier

AMPHAmphastarsupplier

—Amphastar France Pharmaceuticals S.A.Sunlistedsupplier

—Cipla

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

Price

rebased to 0%

XPER, solidMNKD, dashed